The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125502251 12550225 1 I 20160630 20160712 20160712 EXP NL-APOTEX-2016AP009664 APOTEX 63.00 YR F Y 0.00000 20160712 CN NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125502251 12550225 1 PS AMOXICILLIN, CLAVULANATE AMOXICILLINCLAVULANATE POTASSIUM 1 Unknown UNK UNK, UNKNOWN Y 65333 QID
125502251 12550225 2 SS AMOXICILLIN, CLAVULANATE AMOXICILLINCLAVULANATE POTASSIUM 1 Intravenous (not otherwise specified) 1,000/200 MG FOUR TIMES A DAY Y 65333 QID
125502251 12550225 3 SS DIAZEPAM APOTEX, TABLETTEN DIAZEPAM 1 Oral 5 MG, TID Y 0 5 MG TABLET TID
125502251 12550225 4 SS AMITRIPTYLINE HCL APOTEX TABLETTEN AMITRIPTYLINE 1 Unknown 25 MG, QD Y 0 25 MG TABLET
125502251 12550225 5 SS AMITRIPTYLINE HCL APOTEX TABLETTEN AMITRIPTYLINE 1 Unknown 10 MG, QD Y 0 10 MG TABLET
125502251 12550225 6 SS MORPHINE MORPHINE 1 Intrathecal 3.5 MG, PER DAY 0 3.5 MG
125502251 12550225 7 SS MORPHINE MORPHINE 1 Intrathecal 0.5 MG, QD 0 .5 MG
125502251 12550225 8 SS MORPHINE MORPHINE 1 Intrathecal 0.5 MG, QD ON THE FIFTH DAY 0 .5 MG
125502251 12550225 9 SS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Unknown 300 MG, QID Y 0 300 MG QID
125502251 12550225 10 SS CLONIDINE. CLONIDINE 1 Oral 0.15 MG, TID Y 0 .15 MG TID
125502251 12550225 11 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 20 MG, QID Y 0 20 MG QID
125502251 12550225 12 SS DUROGESIC FENTANYL 1 Transdermal 100 ?G, Q.H. Y 0 100 UG /hr
125502251 12550225 13 SS SEVOFLURANE. SEVOFLURANE 1 Unknown UNK, UNKNOWN 0
125502251 12550225 14 SS PROPOFOL. PROPOFOL 1 Unknown UNK, UNKNOWN 0
125502251 12550225 15 SS SUFENTANIL SUFENTANIL 1 Unknown UNK, UNKNOWN 0
125502251 12550225 16 SS ROCURONIUM ROCURONIUM BROMIDE 1 Unknown UNK, UNKNOWN 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125502251 12550225 1 Product used for unknown indication
125502251 12550225 3 Muscle spasms
125502251 12550225 4 Amputation stump pain
125502251 12550225 6 Amputation stump pain
125502251 12550225 9 Product used for unknown indication
125502251 12550225 10 Analgesic therapy
125502251 12550225 11 Analgesic therapy
125502251 12550225 12 Analgesic therapy
125502251 12550225 13 General anaesthesia
125502251 12550225 14 General anaesthesia
125502251 12550225 15 General anaesthesia
125502251 12550225 16 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
125502251 12550225 OT
125502251 12550225 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125502251 12550225 Hemiparesis
125502251 12550225 Implant site infection
125502251 12550225 Infusion site extravasation
125502251 12550225 Off label use
125502251 12550225 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found